Hurdle JG, O'Neill AJ, Chopra I et al.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 9:62-75

Department of Biology, University of Texas at Arlington, Arlington, Texas 76019, USA.
Nature Reviews Microbiology (Impact Factor: 23.57). 01/2011; 9(1):62-75. DOI: 10.1038/nrmicro2474
Source: PubMed


Persistent infections involving slow-growing or non-growing bacteria are hard to treat with antibiotics that target biosynthetic processes in growing cells. Consequently, there is a need for antimicrobials that can treat infections containing dormant bacteria. In this Review, we discuss the emerging concept that disrupting the bacterial membrane bilayer or proteins that are integral to membrane function (including membrane potential and energy metabolism) in dormant bacteria is a strategy for treating persistent infections. The clinical applicability of these approaches is exemplified by the efficacy of lipoglycopeptides that damage bacterial membranes and of the diarylquinoline TMC207, which inhibits membrane-bound ATP synthase. Despite some drawbacks, membrane-active agents form an important new means of eradicating recalcitrant, non-growing bacteria.

Download full-text


Available from: Richard Lee, Dec 17, 2013
  • Source
    • "may quantitatively or qualitatively change their envelope structures as a result of adaptation to developmental signals or environmental cues (Beatty et al., 1994b; Hatch, 1996; Carrasco et al., 2011). The plasticity of the envelope has important implications for the design of control strategies against bacterial infection because of its importance in determining susceptibility to host defenses and antibiotics (Tan et al., 2009; Hurdle et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacteria have evolved specific adaptive responses to cope with changing environments. These adaptations include stress response phenotypes with dynamic modifications of the bacterial cell envelope and generation of membrane vesicles (MVs). The obligate intracellular bacterium, Chlamydia trachomatis, typically has a biphasic lifestyle, but can enter into an altered growth state typified by morphologically aberrant chlamydial forms, termed persistent growth forms, when induced by stress in vitro. How C. trachomatis can adapt to a persistent growth state in host epithelial cells in vivo is not well understood, but is an important question, since it extends the host-bacterial relationship in vitro and has thus been indicated as a survival mechanism in chronic chlamydial infections. Here, we review recent findings on the mechanistic aspects of bacterial adaptation to stress with a focus on how C. trachomatis remodels its envelope, produces MVs, and the potential important consequences of MV production with respect to host-pathogen interactions. Emerging data suggest that the generation of MVs may be an important mechanism for C. trachomatis intracellular survival of stress, and thus may aid in the establishment of a chronic infection in human genital epithelial cells.
    Full-text · Article · Jun 2014 · Frontiers in Cellular and Infection Microbiology
  • Source
    • "The proposed role of hydrogenase enzymes in M. smegmatis. Depicted is a representation of the mycobacterial electron transport chain, adapted from (Hurdle et al., 2011), and with hydrogenases added. The two oxidative hydrogenases Hyd1 and Hyd2 oxidize hydrogen to provide electrons for the respiratory pathway and adenosine triphosphate (ATP) generation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium smegmatis is an obligate aerobe that harbours three predicted [NiFe] hydrogenases, Hyd1 (MSMEG_2262–2263), Hyd2 (MSMEG_2720-2719) and Hyd3 (MSMEG_3931-3928). We show here that these three enzymes differ in their phylogeny, regulation and catalytic activity. Phylogenetic analysis revealed that Hyd1 groups with hydrogenases that oxidize H2 produced by metabolic processes, and Hyd2 is homologous to a novel group of putative high-affinity hydrogenases. Hyd1 and Hyd2 respond to carbon and oxygen limitation, and, in the case of Hyd1, hydrogen supplementation. Hydrogen consumption measurements confirmed that both enzymes can oxidize hydrogen. In contrast, the phylogenetic analysis and activity measurements of Hyd3 are consistent with the enzyme evolving hydrogen. Hyd3 is controlled by DosR, a regulator that responds to hypoxic conditions. The strict dependence of hydrogen oxidation of Hyd1 and Hyd2 on oxygen suggests that the enzymes are oxygen tolerant and linked to the respiratory chain. This unique combination of hydrogenases allows M. smegmatis to oxidize hydrogen at high (Hyd1) and potentially tropospheric (Hyd2) concentrations, as well as recycle reduced equivalents by evolving hydrogen (Hyd3). The distribution of these hydrogenases throughout numerous soil and marine species of actinomycetes suggests that oxic hydrogen metabolism provides metabolic flexibility in environments with changing nutrient fluxes.
    Full-text · Article · Feb 2014 · Environmental Microbiology
  • Source
    • "As discussed by Bolla et al. (2011), an alternate possibility to facilitate the antibiotics to gain access into the cells is to bypass the outer membrane barrier [63]. To bypass the barrier through LPS modifications, chemical facilitators such as detergents, chaotropic agents and polymyxines have been proposed [64, 65]. It is noted that only very limited studies have been reported on the molecular basis of the synergy efficacy between antibiotics and the membrane-active agents and also the study parameters. "
    [Show abstract] [Hide abstract]
    ABSTRACT: For many years, the battle between humans and the multitudes of infection and disease causing pathogens continues. Emerging at the battlefield as some of the most significant challenges to human health are bacterial resistance and its rapid rise. These have become a major concern in global public health invigorating the need for new antimicrobial compounds. A rational approach to deal with antibiotic resistance problems requires detailed knowledge of the different biological and non-biological factors that affect the rate and extent of resistance development. Combination therapy combining conventional antibiotics and essential oils is currently blooming and represents a potential area for future investigations. This new generation of phytopharmaceuticals may shed light on the development of new pharmacological regimes in combating antibiotic resistance. This review consolidated and described the observed synergistic outcome between essential oils and antibiotics, and highlighted the possibilities of essential oils as the potential resistance modifying agent.
    Full-text · Article · Feb 2014 · The Open Microbiology Journal
Show more